Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shuto

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Plos One|July 11, 2013
CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose TemplateChristelle Moreau, Qun Liu, Richard Graeff, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2017
Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitorsTakanori Matsumaru, Makoto Inai, Kana Ishigami, et al.
Journal of Medicinal Chemistry|August 25, 2012
Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activityMitsuhiro Arisawa, Yayoi Kasaya, Tohru Obata, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
Conformational restriction approach to BACE1 inhibitors II: SAR study of the isocytosine derivatives fixed with a cis-cyclopropane ringShuji Yonezawa, Hidekuni Yamakawa, Chie Muto, et al.
Journal of Medicinal Chemistry|March 30, 2017
Discovery of Novel Indazole Derivatives as Orally Available β<sub>3</sub>-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side EffectsYasuhiro Wada, Seiji Nakano, Akifumi Morimoto, et al.
Plos Neglected Tropical Diseases|January 6, 2016
Novel Characteristics of Trypanosoma brucei Guanosine 5'-monophosphate Reductase Distinct from Host AnimalsTomoaki Bessho, Tetsuya Okada, Chihiro Kimura, et al.
Bioorganic & Medicinal Chemistry|October 19, 2019
Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffoldKeisuke Yamamoto, Tomohiro Tamura, Rina Nakamura, et al.
Parasitology|February 2, 2013
Characterization of the novel Trypanosoma brucei inosine 5'-monophosphate dehydrogenaseTomoaki Bessho, Shoko Morii, Toshihide Kusumoto, et al.
Biochemistry|May 23, 2002
Novel hydrolysis-resistant analogues of cyclic ADP-ribose: modification of the "northern" ribose and calcium release activityAndreas H Guse, Céline Cakir-Kiefer, Masayoshi Fukuoka, et al.
Organic Letters|December 17, 2016
Design and Synthesis of Cyclopropane Congeners of Resolvin E2, an Endogenous Proresolving Lipid Mediator, as Its Stable EquivalentsHayato Fukuda, Ryuta Muromoto, Yuuki Takakura, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Plos One|July 11, 2013
CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose TemplateChristelle Moreau, Qun Liu, Richard Graeff, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2017
Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitorsTakanori Matsumaru, Makoto Inai, Kana Ishigami, et al.
Journal of Medicinal Chemistry|August 25, 2012
Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activityMitsuhiro Arisawa, Yayoi Kasaya, Tohru Obata, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
Conformational restriction approach to BACE1 inhibitors II: SAR study of the isocytosine derivatives fixed with a cis-cyclopropane ringShuji Yonezawa, Hidekuni Yamakawa, Chie Muto, et al.
Journal of Medicinal Chemistry|March 30, 2017
Discovery of Novel Indazole Derivatives as Orally Available β<sub>3</sub>-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side EffectsYasuhiro Wada, Seiji Nakano, Akifumi Morimoto, et al.
Plos Neglected Tropical Diseases|January 6, 2016
Novel Characteristics of Trypanosoma brucei Guanosine 5'-monophosphate Reductase Distinct from Host AnimalsTomoaki Bessho, Tetsuya Okada, Chihiro Kimura, et al.
Bioorganic & Medicinal Chemistry|October 19, 2019
Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffoldKeisuke Yamamoto, Tomohiro Tamura, Rina Nakamura, et al.
Parasitology|February 2, 2013
Characterization of the novel Trypanosoma brucei inosine 5'-monophosphate dehydrogenaseTomoaki Bessho, Shoko Morii, Toshihide Kusumoto, et al.
Biochemistry|May 23, 2002
Novel hydrolysis-resistant analogues of cyclic ADP-ribose: modification of the "northern" ribose and calcium release activityAndreas H Guse, Céline Cakir-Kiefer, Masayoshi Fukuoka, et al.
Organic Letters|December 17, 2016
Design and Synthesis of Cyclopropane Congeners of Resolvin E2, an Endogenous Proresolving Lipid Mediator, as Its Stable EquivalentsHayato Fukuda, Ryuta Muromoto, Yuuki Takakura, et al.
Pageof 19